Back to Search Start Over

The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients.

Authors :
Dunn, William G.
Gu, Muxin S.
Fabre, Margarete A.
Cooper, Jonathan
Nomdedeu, Josep F.
Koumas, Laura
Nicolaou, Katerina
Chi, Jiangxiang
Costeas, Paul
Vassiliou, George S.
Source :
Annals of Hematology. Feb2022, Vol. 101 Issue 2, p443-445. 3p.
Publication Year :
2022

Abstract

Dear Editor, Acute promyelocytic leukaemia (APL) is characterized by the presence of the t(15;17) chromosomal translocation that generates the I PML-RARA i fusion gene [[1]]. To determine the sensitivity for detecting each breakpoint by PCR, leukaemic DNA samples were suspended at 20 ng/ L and iteratively diluted tenfold to a dilution of 1:10,000 into equimolar (20 ng/ L) pooled normal blood DNA from 10 healthy subjects. Here, to investigate whether I PML-RARA i is detectable in the blood before APL onset, we study four APL cases with blood DNA available, from the same individual, 2-12 years before diagnosis. [Extracted from the article]

Details

Language :
English
ISSN :
09395555
Volume :
101
Issue :
2
Database :
Academic Search Index
Journal :
Annals of Hematology
Publication Type :
Academic Journal
Accession number :
154567455
Full Text :
https://doi.org/10.1007/s00277-021-04472-5